Incidence and risk factors for developing venous thromboembolism (VTE) in Japanese patients with diffuse large B-cell lymphoma (DLBCL)

被引：0
|
作者：
Yokoyama, K. [1 ]
Murata, M. [2 ]
Ikeda, Y. [3 ]
Okamoto, S. [1 ]
机构：
[1] Keio Univ, Sch Med, Dept Med, Div Hematol, Tokyo 108, Japan
[2] Keio Univ, Sch Med, Dept Lab Med, Tokyo 108, Japan
[3] Waseda Univ, Grad Sch Adv Sci & Engn, Tokyo, Japan
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2011年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：37 / 38
页数：2
相关论文
共 50 条
  • [11] The Application of the ThroLy Risk Assessment Model to Predict Venous Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma
    Abdel-Razeq, Hikmat
    Ma'koseh, Mohammad
    Mansour, Asem
    Bater, Rayan
    Amarin, Rula
    Abufara, Alaa
    Halahleh, Khalid
    Manassra, Mohammad
    Alrwashdeh, Mohammad
    Almomani, Mohammad
    Zmaily, Mais
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2021, 27
  • [12] Outcomes of Patients with Transformed Diffuse Large B-Cell Lymphoma (DLBCL)
    Nakashima, J.
    Cruz-Chamarro, R.
    Laborde, J.
    Kim, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E479 - E479
  • [13] Risk Factors for Early Death after Immunochemotherapy in Older Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
    Mantripragada, Kalyan
    Castillo, Jorge J.
    Olszewski, Adam J.
    BLOOD, 2015, 126 (23)
  • [14] Leukocyte Subtypes As Predictors for Venous Thromboembolism in Diffuse Large B-Cell Lymphoma
    Gollamudi, Jahnavi
    Dharmavaram, Gouri
    Martin, Petra
    Boughan, Kirsten Marie
    Cooper, Brenda
    Gallogly, Molly M.
    Malek, Ehsan
    Metheny, Leland
    Otegbeye, Folashade
    Tomlinson, Benjamin K.
    de Lima, Marcos
    Nayak, Lalitha V.
    Caimi, Paolo
    BLOOD, 2018, 132
  • [15] Increased risk of venous thromboembolism in patients with primary mediastinal large B-cell lymphoma
    Lekovic, Danijela
    Miljic, Predrag
    Mihaljevic, Biljana
    THROMBOSIS RESEARCH, 2010, 126 (06) : 477 - 480
  • [16] Non-O Blood Group and Pretreatment Risk of Venous Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma
    Otasevic, Vladimir
    Ivanovic, Jelena
    Vukovic, Vojin
    Milic, Natasa
    Kozarac, Sofija
    Pesic, Andrej
    Mihaljevic, Biljana
    Fareed, Jawed
    Antic, Darko
    BLOOD, 2023, 142
  • [17] Consequences of immune defects in patients with diffuse large B-cell lymphoma (DLBCL)
    Flatman, Katarina
    Morfett, Samuel
    Ahearne, Matthew
    Allchin, Rebecca
    Balotis, Constantine
    Kennedy, Ben
    Ladani, Sapna
    Miall, Fiona
    Jayne, Sandrine
    Walter, Harriet
    Dyer, Martin
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 : 189 - 189
  • [18] Mutational Landscape of Diffuse Large B-Cell Lymphoma (DLBCL) in Mexican Patients
    Candelaria, Myrna
    Gutierrez-Hernandez, Olga
    Diaz-Chavez, Jose
    Cerrato, Dennis
    Gutierrez-Ramirez, Francisco J.
    Aviles, Alejandro
    BLOOD, 2023, 142
  • [19] Factors influencing time to initiation of chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)
    Danese, M.
    Gleeson, M.
    Reyes, C.
    Pao, M.
    Pao, K.
    ANNALS OF ONCOLOGY, 2008, 19 : 216 - 216
  • [20] Factors influencing time to initiation of chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)
    Reyes, C.
    Knopf, K. B.
    Gleeson, M.
    Danese, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345